Rituximab therapy in patients with refractory dermatomyositis or polymyositis: differential effects in a real-life population.

Unger, Leonore

Rituximab therapy in patients with refractory dermatomyositis or polymyositis: differential effects in a real-life population. [electronic resource] - Rheumatology (Oxford, England) Sep 2014 - 1630-8 p. digital

Publication Type: Journal Article; Multicenter Study

1462-0332

10.1093/rheumatology/keu024 doi


Adult
Aged
Aged, 80 and over
Antibodies, Monoclonal, Murine-Derived--adverse effects
Biomarkers--blood
Creatine Kinase--blood
Dermatomyositis--drug therapy
Drug Administration Schedule
Drug Therapy, Combination
Female
Glucocorticoids--administration & dosage
Humans
Immunosuppressive Agents--adverse effects
Male
Middle Aged
Polymyositis--drug therapy
Prednisolone--administration & dosage
Retrospective Studies
Rituximab
Total Lung Capacity--drug effects
Treatment Outcome